← Back to patent-cliff list
CAS 2189684-53-3
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
Chain position details for this CAS are not yet recorded.
Intermediates available on this site
Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.
| Supplier | Product | Price band | MOQ | Lead time | Qualifications | Action |
|---|---|---|---|---|---|---|
| Qualified Partner — East China API Works | 4-Chloro-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(2,2,2-trifluoroethyl)-1H-indazol-3-amine Pharmaceutical Intermediates | On request | On request | On request | — |
Listed key intermediates
| Product / CAS | Purity / impurities | Capacity | Qualifications | Packing / cold chain | MOQ / price band | Action |
|---|---|---|---|---|---|---|
Lenacapavir INT-2 | 4- chloro -7- boronate indazole 2189684-53-3 | ≥98.5% | 900 kg/yr | US DMFCold chain | 1 kg / 5 kg aluminium bottle · Cold chain | 0.5 kg · US$ 4,200-6,000 / kg |
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.